These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


401 related items for PubMed ID: 26729015

  • 1. Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses.
    Kawai T, Tominaga S, Hiroi S, Ogata S, Nakanishi K, Kawahara K, Sonobe H, Hiroshima K.
    J Clin Pathol; 2016 Aug; 69(8):706-12. PubMed ID: 26729015
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Highly expressed EZH2 in combination with BAP1 and MTAP loss, as detected by immunohistochemistry, is useful for differentiating malignant pleural mesothelioma from reactive mesothelial hyperplasia.
    Yoshimura M, Kinoshita Y, Hamasaki M, Matsumoto S, Hida T, Oda Y, Iwasaki A, Nabeshima K.
    Lung Cancer; 2019 Apr; 130():187-193. PubMed ID: 30885343
    [Abstract] [Full Text] [Related]

  • 6. Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study.
    Xing D, Banet N, Sharma R, Vang R, Ronnett BM, Illei PB.
    Hum Pathol; 2018 Feb; 72():160-166. PubMed ID: 29241740
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry.
    Hida T, Hamasaki M, Matsumoto S, Sato A, Tsujimura T, Kawahara K, Iwasaki A, Okamoto T, Oda Y, Honda H, Nabeshima K.
    Lung Cancer; 2017 Feb; 104():98-105. PubMed ID: 28213009
    [Abstract] [Full Text] [Related]

  • 9. The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study.
    Ordóñez NG.
    Mod Pathol; 2006 Jan; 19(1):34-48. PubMed ID: 16056246
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas.
    Ordóñez NG.
    Hum Pathol; 2005 Nov; 36(11):1163-7. PubMed ID: 16260268
    [Abstract] [Full Text] [Related]

  • 12. 5-hmC loss is another useful tool in addition to BAP1 and MTAP immunostains to distinguish diffuse malignant peritoneal mesothelioma from reactive mesothelial hyperplasia in peritoneal cytology cell-blocks and biopsies.
    Alsugair Z, Kepenekian V, Fenouil T, Glehen O, Villeneuve L, Isaac S, Hommell-Fontaine J, Benzerdjeb N.
    Virchows Arch; 2022 Jul; 481(1):23-29. PubMed ID: 35575935
    [Abstract] [Full Text] [Related]

  • 13. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.
    Laury AR, Hornick JL, Perets R, Krane JF, Corson J, Drapkin R, Hirsch MS.
    Am J Surg Pathol; 2010 May; 34(5):627-35. PubMed ID: 20414098
    [Abstract] [Full Text] [Related]

  • 14. MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung.
    Mawas AS, Amatya VJ, Kushitani K, Kai Y, Miyata Y, Okada M, Takeshima Y.
    Sci Rep; 2018 Jan 09; 8(1):134. PubMed ID: 29317712
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells.
    Minato H, Kurose N, Fukushima M, Nojima T, Usuda K, Sagawa M, Sakuma T, Ooi A, Matsumoto I, Oda M, Arano Y, Shimizu J.
    Am J Clin Pathol; 2014 Jan 09; 141(1):85-93. PubMed ID: 24343741
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas.
    Chiosea S, Krasinskas A, Cagle PT, Mitchell KA, Zander DS, Dacic S.
    Mod Pathol; 2008 Jun 09; 21(6):742-7. PubMed ID: 18327208
    [Abstract] [Full Text] [Related]

  • 20. Use of Anti-Noxa Antibody for Differential Diagnosis between Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia.
    Kushitani K, Amatya VJ, Mawas AS, Miyata Y, Okada M, Takeshima Y.
    Pathobiology; 2016 Jun 09; 83(1):33-40. PubMed ID: 26735863
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.